Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
JCO Global Oncology|April 22, 2020
Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated CholangiocarcinomaSarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, et al.Genome Research|July 26, 2017
Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumorsMi Ni Huang, Willie Yu, Wei Wei Teoh, et al.Science Translational Medicine|October 20, 2017
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout AsiaAlvin W T Ng, Song Ling Poon, Mi Ni Huang, et al.Genome Medicine|May 28, 2015
Mutation signatures implicate aristolochic acid in bladder cancer developmentSong Ling Poon, Mi Ni Huang, Yang Choo, et al.European Journal of Cancer (Oxford, England : 1990)|October 27, 2019
DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trialRaghav Sundar, Alvin Ng, Hermioni Zouridis, et al.NAR Genomics and Bioinformatics|February 12, 2021
A functional network of gastric-cancer-associated splicing events controlled by dysregulated splicing factorsShanshan Cheng, Debleena Ray, Raymond Teck Ho Lee, et al.Journal of Medical Genetics|January 26, 2013
Whole exome sequencing identifies a mutation for a novel form of corneal intraepithelial dyskeratosisVincent José Soler, Khanh-Nhat Tran-Viet, Stéphane D Galiacy, et al.Nature|February 7, 2020
The repertoire of mutational signatures in human cancerLudmil B Alexandrov, Jaegil Kim, Nicholas J Haradhvala, et al.Gastroenterology|May 21, 2013
Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracilZhengdeng Lei, Iain Beehuat Tan, Kakoli Das, et al.Nature Genetics|July 21, 2014
Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenomaWeng Khong Lim, Choon Kiat Ong, Jing Tan, et al.Pageof 7